Phase 3 Chronic Fatigue Syndrome Trial, Not Yet Recruiting (NCT06739720)

Phase 3 Chronic Fatigue Syndrome Trial, Not Yet Recruiting NCT06739720 Sponsor: The University of Hong Kong Condition: Chronic Fatigue Syndrome

Printed from Voxsanity (voxsanity.com.au) — NCT06739720 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Fatigue Syndrome

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You have been diagnosed with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME), or you have ongoing tiredness/fatigue following a COVID-19 infection
You are able to take part in and complete a 6-week treatment programme
You are able to fill in online fatigue questionnaires that have been scientifically tested for accuracy

Who may not be able to join:

You have used any supplements or herbal medicines in the last six months
You have a serious health condition that could prevent you from fully taking part in the programme (confirm with trial site)
You have been diagnosed with acute inflammation (a recent, active inflammatory condition in your body)
You are pregnant or planning to become pregnant within the next 3 months

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Phone: +852 5660 4020

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06739720

Sponsor: The University of Hong Kong

Phase: Phase 3

Status: Not Yet Recruiting

Condition: Chronic Fatigue Syndrome

Trial contact: +852 5660 4020

More information: https://clinicaltrials.gov/study/NCT06739720

Eligibility summary (AI generated)

Written by an AI model from the ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You have been diagnosed with Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME), or you have ongoing tiredness/fatigue following a COVID-19 infection
You are able to take part in and complete a 6-week treatment programme
You are able to fill in online fatigue questionnaires that have been scientifically tested for accuracy

Who may not be able to join:

You have used any supplements or herbal medicines in the last six months
You have a serious health condition that could prevent you from fully taking part in the programme (confirm with trial site)
You have been diagnosed with acute inflammation (a recent, active inflammatory condition in your body)
You are pregnant or planning to become pregnant within the next 3 months

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Not Yet Recruiting

Phase

Phase 3

Sponsor

The University of Hong Kong

Registry

ClinicalTrials.gov

Start date

2 January 2025

Est. completion

30 June 2026

Where this trial is recruiting

Hong Kong

Primary endpoints

Mean difference in Chalder Fatigue Score

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov